Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

INTRODUCTION: Twenty-five percent of stage II colon cancer (CC) patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery. We hypothesise that subtypes of MRD, defined by circulating tumour cells (CTCs) and bone marrow micrometastasis (mM), have different types...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ecancermedicalscience
Egile Nagusiak: Murray, Nigel P, Aedo, Socrates, Villalon, Ricardo, Albarran, Vidal, Orrego, Shenda, Guzman, Eghon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cancer Intelligence 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652547/
https://ncbi.nlm.nih.gov/pubmed/33209110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1119
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak